Commonwealth Equity Services LLC Raises Holdings in Bruker Co. (NASDAQ:BRKR)

Commonwealth Equity Services LLC raised its position in shares of Bruker Co. (NASDAQ:BRKRFree Report) by 78.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,123 shares of the medical research company’s stock after acquiring an additional 6,631 shares during the period. Commonwealth Equity Services LLC’s holdings in Bruker were worth $1,421,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Lindbrook Capital LLC lifted its position in Bruker by 68.2% during the fourth quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock valued at $26,000 after buying an additional 146 shares in the last quarter. Baker Tilly Wealth Management LLC lifted its stake in shares of Bruker by 3.0% during the fourth quarter. Baker Tilly Wealth Management LLC now owns 5,285 shares of the medical research company’s stock worth $388,000 after purchasing an additional 156 shares in the last quarter. Lifestyle Asset Management Inc. grew its stake in shares of Bruker by 1.3% in the first quarter. Lifestyle Asset Management Inc. now owns 12,534 shares of the medical research company’s stock valued at $1,177,000 after buying an additional 158 shares in the last quarter. Legacy Wealth Asset Management LLC raised its holdings in shares of Bruker by 5.7% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 3,412 shares of the medical research company’s stock valued at $251,000 after buying an additional 184 shares during the period. Finally, Park Place Capital Corp lifted its position in Bruker by 19.4% during the 1st quarter. Park Place Capital Corp now owns 1,139 shares of the medical research company’s stock worth $107,000 after acquiring an additional 185 shares in the last quarter. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Bruker Trading Down 0.3 %

NASDAQ:BRKR opened at $61.65 on Friday. The company has a market cap of $8.96 billion, a PE ratio of 22.42, a P/E/G ratio of 2.09 and a beta of 1.20. The business’s 50 day moving average is $69.63 and its two-hundred day moving average is $77.01. The company has a quick ratio of 0.91, a current ratio of 1.81 and a debt-to-equity ratio of 0.95. Bruker Co. has a 52 week low of $53.79 and a 52 week high of $94.86.

Bruker (NASDAQ:BRKRGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical research company reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.07. The firm had revenue of $721.70 million for the quarter, compared to analysts’ expectations of $729.88 million. Bruker had a return on equity of 27.31% and a net margin of 13.38%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the business posted $0.64 earnings per share. On average, analysts predict that Bruker Co. will post 2.66 EPS for the current year.

Bruker Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 17th. Shareholders of record on Monday, June 3rd were issued a $0.05 dividend. The ex-dividend date was Monday, June 3rd. This represents a $0.20 dividend on an annualized basis and a yield of 0.32%. Bruker’s dividend payout ratio is currently 7.27%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on BRKR shares. StockNews.com lowered shares of Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Bank of America dropped their price target on shares of Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, May 20th. The Goldman Sachs Group raised their target price on Bruker from $66.00 to $74.00 and gave the company a “sell” rating in a research note on Wednesday, April 10th. Jefferies Financial Group assumed coverage on Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target on the stock. Finally, Stifel Nicolaus lowered their price objective on Bruker from $81.00 to $77.00 and set a “hold” rating for the company in a research note on Monday, May 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $85.00.

Get Our Latest Analysis on Bruker

Bruker Company Profile

(Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Read More

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.